What Happened?
Lexington, MA-based Sentien Biotechnologies Inc Appointed Rita Barcia as Director of Research & Development
About the Company
Sentien Biotechnologies, Inc. is a privately owned, clinical stage company developing novel approaches to cell therapy. Our lead product is designed to allow for controlled, sustained delivery of mesenchymal stem cell (MSC) secreted factors. This approach immobilizes the MSCs in an extracorporeal device, allowing for doses of therapeutic secreted factors that are unattainable by direct injection.
About the Person
Rita Barcia is Director of R&D at Sentien Biotechnologies Inc. Previously, Rita held various senior HR leadership roles in the industry.
Info Source
News
Short Profile